NO963374L - Substituerte 4H-pyraner - Google Patents
Substituerte 4H-pyranerInfo
- Publication number
- NO963374L NO963374L NO963374A NO963374A NO963374L NO 963374 L NO963374 L NO 963374L NO 963374 A NO963374 A NO 963374A NO 963374 A NO963374 A NO 963374A NO 963374 L NO963374 L NO 963374L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- substituted
- pyrans
- branched alkyl
- straight chain
- Prior art date
Links
- 150000000531 4H-pyrans Chemical class 0.000 title abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Det blir beskrevet substituerte 4H-pyraner med den generelle formel (I) hvor A står for cykloalkyl med 3 til 6 karbonatomer eller for rettkjedet eller forgrenet alkyl med opptil 8 karbonatomer, eller står for aryl med 6 til 10 karbonatomer eller for pyridyl, som eventuelt er substituert, r1 og r2 er like eller forskjellige og står for hydrogen, amino eller rettkjedet eller forgrenet alkyl, alkoksy eller alkylamino, alle med opptil 8 karbonatomer, r3 og R4 er like eller forskjellige og står for rettkjedet eller forgrenet alkyl eller acyl med alltid opptil 6 karbonatomer, og deres salter. Det blir dessuten beskrevet en fremgangsmåte for fremstilling av substituerte 4H-pyraner, samt deres anvendelse som virkestoff i legemidler, spesielt for behandling av sykdommer i det sentrale nervesystem.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19529858A DE19529858A1 (de) | 1995-08-14 | 1995-08-14 | Substituierte 4H-Pyrane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO963374D0 NO963374D0 (no) | 1996-08-13 |
| NO963374L true NO963374L (no) | 1997-02-17 |
Family
ID=7769442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963374A NO963374L (no) | 1995-08-14 | 1996-08-13 | Substituerte 4H-pyraner |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5760073A (no) |
| EP (1) | EP0758648B1 (no) |
| JP (1) | JPH0959271A (no) |
| KR (1) | KR970010758A (no) |
| CN (1) | CN1147512A (no) |
| AT (1) | ATE190611T1 (no) |
| AU (1) | AU708956B2 (no) |
| CA (1) | CA2183048A1 (no) |
| CZ (1) | CZ239496A3 (no) |
| DE (2) | DE19529858A1 (no) |
| DK (1) | DK0758648T3 (no) |
| EE (1) | EE9600114A (no) |
| ES (1) | ES2145355T3 (no) |
| GR (1) | GR3033357T3 (no) |
| HU (1) | HUP9602220A3 (no) |
| IL (1) | IL119054A (no) |
| MX (1) | MX9603342A (no) |
| NO (1) | NO963374L (no) |
| NZ (1) | NZ299145A (no) |
| PL (1) | PL315652A1 (no) |
| PT (1) | PT758648E (no) |
| RU (1) | RU2164915C2 (no) |
| SI (1) | SI0758648T1 (no) |
| SK (1) | SK105596A3 (no) |
| ZA (1) | ZA966832B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2329739T3 (es) * | 1997-04-07 | 2009-11-30 | Georgetown University | Analogos de cocaina. |
| US6221550B1 (en) | 2000-03-31 | 2001-04-24 | Nexpress Solutions Llc | 4H-pyran charge control agents for electrostatographic toners and developers |
| WO2009006580A1 (en) * | 2007-07-05 | 2009-01-08 | Cv Therapeutics, Inc. | Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
| US20090012103A1 (en) | 2007-07-05 | 2009-01-08 | Matthew Abelman | Substituted heterocyclic compounds |
| JP5120070B2 (ja) * | 2008-05-29 | 2013-01-16 | 三浦工業株式会社 | 水処理装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1995
- 1995-08-14 DE DE19529858A patent/DE19529858A1/de not_active Withdrawn
-
1996
- 1996-08-01 DK DK96112427T patent/DK0758648T3/da active
- 1996-08-01 EP EP96112427A patent/EP0758648B1/de not_active Expired - Lifetime
- 1996-08-01 AT AT96112427T patent/ATE190611T1/de not_active IP Right Cessation
- 1996-08-01 ES ES96112427T patent/ES2145355T3/es not_active Expired - Lifetime
- 1996-08-01 SI SI9630155T patent/SI0758648T1/xx unknown
- 1996-08-01 PT PT96112427T patent/PT758648E/pt unknown
- 1996-08-01 DE DE59604649T patent/DE59604649D1/de not_active Expired - Fee Related
- 1996-08-07 AU AU61931/96A patent/AU708956B2/en not_active Ceased
- 1996-08-07 US US08/692,964 patent/US5760073A/en not_active Expired - Fee Related
- 1996-08-09 CA CA002183048A patent/CA2183048A1/en not_active Abandoned
- 1996-08-09 NZ NZ299145A patent/NZ299145A/en unknown
- 1996-08-12 CN CN96111368A patent/CN1147512A/zh active Pending
- 1996-08-12 PL PL96315652A patent/PL315652A1/xx unknown
- 1996-08-12 JP JP8227366A patent/JPH0959271A/ja active Pending
- 1996-08-12 IL IL11905496A patent/IL119054A/xx not_active IP Right Cessation
- 1996-08-13 EE EE9600114A patent/EE9600114A/xx unknown
- 1996-08-13 CZ CZ962394A patent/CZ239496A3/cs unknown
- 1996-08-13 MX MX9603342A patent/MX9603342A/es unknown
- 1996-08-13 KR KR1019960033535A patent/KR970010758A/ko not_active Application Discontinuation
- 1996-08-13 SK SK1055-96A patent/SK105596A3/sk unknown
- 1996-08-13 ZA ZA9606832A patent/ZA966832B/xx unknown
- 1996-08-13 HU HU9602220A patent/HUP9602220A3/hu unknown
- 1996-08-13 NO NO963374A patent/NO963374L/no not_active Application Discontinuation
- 1996-08-14 RU RU96115463/04A patent/RU2164915C2/ru active
-
2000
- 2000-05-05 GR GR20000401042T patent/GR3033357T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0758648T3 (da) | 2000-07-24 |
| RU2164915C2 (ru) | 2001-04-10 |
| ZA966832B (en) | 1997-02-20 |
| NO963374D0 (no) | 1996-08-13 |
| JPH0959271A (ja) | 1997-03-04 |
| CN1147512A (zh) | 1997-04-16 |
| SI0758648T1 (en) | 2000-06-30 |
| CZ239496A3 (en) | 1997-03-12 |
| AU6193196A (en) | 1997-02-20 |
| DE19529858A1 (de) | 1997-02-20 |
| AU708956B2 (en) | 1999-08-19 |
| GR3033357T3 (en) | 2000-09-29 |
| HUP9602220A3 (en) | 1998-04-28 |
| SK105596A3 (en) | 1997-03-05 |
| ATE190611T1 (de) | 2000-04-15 |
| ES2145355T3 (es) | 2000-07-01 |
| PT758648E (pt) | 2000-08-31 |
| HU9602220D0 (en) | 1996-10-28 |
| US5760073A (en) | 1998-06-02 |
| EP0758648A1 (de) | 1997-02-19 |
| EP0758648B1 (de) | 2000-03-15 |
| DE59604649D1 (de) | 2000-04-20 |
| EE9600114A (et) | 1997-02-17 |
| MX9603342A (es) | 1997-03-29 |
| KR970010758A (ko) | 1997-03-27 |
| HUP9602220A2 (en) | 1997-05-28 |
| CA2183048A1 (en) | 1997-02-15 |
| IL119054A (en) | 2000-10-31 |
| NZ299145A (en) | 1998-03-25 |
| IL119054A0 (en) | 1996-11-14 |
| PL315652A1 (en) | 1997-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101208A (en) | Phenyl-piperazine anti-arrhythmia agents. | |
| NO923466L (no) | Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser | |
| NO922940L (no) | Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem | |
| AU671933B2 (en) | The administration of monoamine acridine in cholinergic neuronal deficit states | |
| NO972881L (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
| MY105402A (en) | 17-beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation. | |
| HUP0001062A2 (hu) | NAALADáz gátló hatású foszfinsavszármazékokat tartalmazó gyógyászati készítmények | |
| NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| IL104154A0 (en) | Saccharin derivatives,their preparation and pharmaceutical compositions containing them | |
| NO964667L (no) | Purin-6-on-derivater | |
| HU9301155D0 (en) | Methods for producing steroide derivatives and for their application in medical treatment | |
| NO934196L (no) | N,N-disubstituerte arylcykloalkylaminer, deres salter, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for deres fremstilling | |
| NO961000L (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike | |
| DE68923151D1 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
| DE68908145D1 (de) | Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien. | |
| US5330978B1 (en) | Phosphonic acid derivatives and use thereof | |
| NO963374L (no) | Substituerte 4H-pyraner | |
| HU9201033D0 (en) | Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
| ATE43140T1 (de) | Derivate von enzym-hemmender griseolsaeure und deren verwendung. | |
| PT85866A (en) | Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives | |
| NO931752D0 (no) | Oktahydronaftalenoksimderivater til inhibering av kolesterolbiosyntese, samt fremgangsmaate til fremstilling og anvendelse derav | |
| NO985974L (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
| DK1025101T3 (da) | Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |